Abstract:The signaling pathway of the microtubule-associated protein kinase or extracellular regulated kinase (MAPK/ERK) is a common mechanism of extracellular information transduction from extracellular stimuli to the intracellular space. The transduction of information leads to changes in the ongoing metabolic pathways and the modification of gene expression patterns. In the central nervous system, ERK is expressed ubiquitously, both temporally and spatially. As for the temporal ubiquity, this signaling system participates in three key moments: (i) Embryonic development; (ii) the early postnatal period; and iii) adulthood. During embryonic development, the system is partly responsible for the patterning of segmentation in the encephalic vesicle through the FGF8-ERK pathway. In addition, during this period, ERK directs neurogenesis migration and the final fate of neural progenitors. During the early postnatal period, ERK participates in the maturation process of dendritic trees and synaptogenesis. During adulthood, ERK participates in social and emotional behavior and memory processes, including long-term potentiation. Alterations in mechanisms related to ERK are associated with different pathological outcomes. Genetic alterations in any component of the ERK pathway result in pathologies associated with neural crest derivatives and mental dysfunctions associated with autism spectrum disorders. The MAP-ERK pathway is a key element of the neuroinflammatory pathway triggered by glial cells during the development of neurodegenerative diseases, such as Parkinson's and Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis, as well as prionic diseases. The process triggered by MAPK/ERK activation depends on the stage of development (mature or senescence), the type of cellular element in which the pathway is activated, and the anatomic neural structure. However, extensive gaps exist with regards to the targets of the phosphorylated ERK in many of these processes.

Evaluation of information flows in the RAS-MAPK system using transfer entropy measurements

Assessing transfer entropy from biochemical data

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

Sensitivity analysis predicts that the ERK-pMEK interaction regulates ERK nuclear translocation

Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer

Targeted Perturb-seq Reveals EGR1 and FOS as Key Regulators of the Transcriptional RAF-MAPK Response

Dependence of MAPK mediated signaling on Erk isoforms and differences in nuclear shuttling

NMR Characterization of Information Flow and Allosteric Communities in the MAP Kinase p38γ

The MEK/ERK Network as a Therapeutic Target in Human Cancer

COP1/DET1/ETS Axis Regulates ERK Transcriptome and Sensitivity to MAPK Inhibitors

Simulation of Crosstalk Between Small GTPase RhoA and EGFR-ERK Signaling Pathway Via MEKK1

Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway

MAPK's networks and their capacity for multistationarity due to toric steady states

Signaling from RAS to RAF: The Molecules and Their Mechanisms

Toward Modeling Context-Specific EMT Regulatory Networks Using Temporal Single Cell RNA-Seq Data

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes

Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics

Modeling RAS phenotype in colorectal cancer uncovers novel molecular traits of RAS dependency and improves prediction of response to targeted agents in patients

Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Precise Readout of MEK1 Proteoforms upon MAPK Pathway Modulation by Individual Ion Mass Spectrometry